Active	Status	Sponsor type	Region	Phase	Filter
3 Active 4 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Martin, Luis C
NCT04681170 / 2019-002278-30: Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)	Completed	3	46	Europe, RoW	Lomitapide	Amryt Pharma, Amryt Pharmaceuticals DAC	Homozygous Familial Hypercholesterolaemia (HoFH)	10/22	06/24
Neptuno, NCT04784559 / 2020-005951-19: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection	Terminated	3	205	Europe, RoW	Plitidepsin, Dexamethasone, Remdesivir, Favipiravir	PharmaMar	COVID-19 Infection	03/23	03/23
ACHIEVE, NCT03020303 / 2020-001882-36: Aldosterone BloCkade for Health Improvement EValuation in End-stage Renal Disease	Recruiting	3	2750	Europe, Canada, RoW	Spironolactone 25Mg Tablet, Placebo Oral Tablet	Population Health Research Institute, Canadian Institutes of Health Research (CIHR)	Endstage Renal Disease	07/25	04/26
Bassan, Rodrigo
No trials found
Furlan, Natalia
No trials found